Blood CD33(+)HLA-DR(−) myeloid-derived suppressor cells are increased with age and a history of cancer
Open accessThe DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Abstract
Myeloid-derived suppressor cells are increased with age and elevated in donors with a history of cancer; an age-related effect has never been shown in humans. As we age, the composition of our peripheral leukocytes changes dramatically. Many of these alterations contribute to the general immune dysfunction that burdens the elderly, which in turn, contributes to increased susceptibility to disease. MDSCs represent a heterogeneous population of immunosuppressive leukocytes that are elevated in the peripheral blood of cancer patients. Given the relation between cancer incidence and age, this study examined the frequency of peripheral blood CD33(+)HLA-DR(−) MDSCs across three cohorts: healthy adults (19–59 years old), community-dwelling seniors (61–76 years old), and frail elderly (67–99 years old). This analysis is the first to demonstrate that MDSCs and specifically the CD11b(+)CD15(+) MDSC subset are increased with age. Proinflammatory cytokines that are required for the differentiation of MDSCs (e.g., TNF-α, IL-6, and IL-1β) were similarly found to be increased in the serum of the frail elderly. Furthermore, the proportion of MDSCs and the CD11b(+)CD15(+) subset were found to be elevated significantly in elderly donors with a history of cancer. This age-related elevation in the frequency of MDSCs may contribute to the increased cancer incidence that occurs with age. Further investigation into the functional consequences of elevated MDSCs will provide valuable insight into the progression of age-related pathologies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“IL-6 is elevated with age and coincides with increases in both circulating immunosuppressive myeloid cells and cancer incidence26.”
From Stromal senescence establishes an immunosuppressive microenvironment that drives tumorigenesis (2016) · cites this paper as [6]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Myeloid-derived-suppressor cells as regulators of the immune system
Gabrilovich, D. I., & Nagaraj, S. (2009) · Nature Reviews Immunology · doi:10.1038/nri2506 · Cited by 6,753 · cited 1×
“sive, myeloid lineage cells in the peripheral blood [4].”
BackgroundDiaz-Montero, C. M., Salem, M. L., Nishimura, M. I., Garrett-Mayer, E., Cole, D. J., & Montero, A. J. (2009) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-008-0523-4 · Cited by 1,215 · cited 1×
“been found to be associated with clinical scores, such as tumor stage, burden, and metastasis [10, 15].”
BackgroundInflammatory markers in population studies of aging
Singh, T., & Newman, A. B. (2011) · Ageing Research Reviews · doi:10.1016/j.arr.2010.11.002 · Cited by 863 · cited 1×
“[19]).”
Ko, J. S., Zea, A. H., Rini, B. I., Ireland, J. L., Elson, P., Cohen, P., Golshayan, A., Rayman, P. A., Wood, L., Garcia, J., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-1332 · Cited by 862 · cited 8×
“MDSCs (CD33 HLA-DR ) and the CD11b CD15 MDSC subset were found to be increased significantly in seniors (0.29 0.03 and 0.17 0.03, respectively) and the frail elderly (0.40 0.03 and 0.29 0.02, respectively) as compared with healthy adults (0.22 0.03 and 0.11 0.03, respectively; Fig.”
BackgroundInfluentialLechner, M. G., Liebertz, D. J., & Epstein, A. L. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1000901 · Cited by 582 · cited 2×
“Furthermore, serum IL-6 has been shown to be correlated with MDSC frequency in patients with gastrointestinal cancer [20], and as mentioned above, proinflammatory cytokines are able to induce the differentiation of MDSCs in vitro [5, 8, 21].”
BackgroundRockwood, K., Song, X., & Mitnitski, A. (2011) · Canadian Medical Association Journal · doi:10.1503/cmaj.101271 · Cited by 573
Hearps, A. C., Martin, G. E., Angelovich, T. A., Cheng, W., Maisa, A., Landay, A. L., Jaworowski, A., & Crowe, S. M. (2012) · Aging Cell · doi:10.1111/j.1474-9726.2012.00851.x · Cited by 547
Obermajer, N., Muthuswamy, R., Lesnock, J., Edwards, R. P., & Kalinski, P. (2011) · Blood · doi:10.1182/blood-2011-07-365825 · Cited by 497
Inflammaging: disturbed interplay between autophagy and inflammasomes
Salminen, A., Kaarniranta, K., & Kauppinen, A. (2012) · Aging · doi:10.18632/aging.100444 · Cited by 453
Myeloid derived suppressor cells in human diseases
Greten, T. F., Manns, M. P., & Korangy, F. (2011) · International Immunopharmacology · doi:10.1016/j.intimp.2011.01.003 · Cited by 398 · cited 1×
“categories [6, 7].”
Research works printed but not linked: 1
- 2001, The 65 Years and Older Population: 2000. Census 2000 Brief
Cited by
Understanding the tumor immune microenvironment (TIME) for effective therapy
Binnewies, M., Roberts, E. W., Kersten, K., Chan, V., Fearon, D. F., Merad, M., Coussens, L. M., Gabrilovich, D. I., Ostrand-Rosenberg, S., Hedrick, C. C., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0014-x · Cited by 6,145
Age-dependent dysregulation of innate immunity
Shaw, A. C., Goldstein, D. R., & Montgomery, R. R. (2013) · Nature Reviews Immunology · doi:10.1038/nri3547 · Cited by 1,061
How the ageing microenvironment influences tumour progression
Fane, M., & Weeraratna, A. T. (2020) · Nature Reviews Cancer · doi:10.1038/s41568-019-0222-9 · Cited by 849
Stromal senescence establishes an immunosuppressive microenvironment that drives tumorigenesis
Ruhland, M. K., Loza, A. J., Capietto, A.-H., Luo, X., Knolhoff, B. L., Flanagan, K. C., Belt, B. A., Alspach, E., Leahy, K., Luo, J., et al. (2016) · Nature Communications · doi:10.1038/ncomms11762 · Cited by 496
Myeloid-Derived Suppressor Cells
(2015) · Advances in Cancer Research · doi:10.1016/bs.acr.2015.04.002 · Cited by 482
“Since MDSCs produce IL-6 and IL-1β, these studies also raise the question of whether MDSC production of IL-6 is regulated by IL-1β, and if MDSC production of IL-1β enhances MDSC production of IL-6.”
BackgroundThe interplay between immunosenescence and age-related diseases
Barbé-Tuana, F., Funchal, G., Schmitz, C. R. R., Maurmann, R. M., & Bauer, M. E. (2020) · Seminars in Immunopathology · doi:10.1007/s00281-020-00806-z · Cited by 384
Transcriptional regulation of myeloid-derived suppressor cells
Condamine, T., Mastio, J., & Gabrilovich, D. I. (2015) · Journal of Leukocyte Biology · doi:10.1189/jlb.4ri0515-204r · Cited by 372
“frequency has also been reported to increase with aging [5, 6].”
BackgroundThe integration of inflammaging in age-related diseases
Fulop, T., Witkowski, J. M., Olivieri, F., & Larbi, A. (2018) · Seminars in Immunology · doi:10.1016/j.smim.2018.09.003 · Cited by 348
Induction of myelodysplasia by myeloid-derived suppressor cells
Chen, X., Eksioglu, E. A., Zhou, J., Zhang, L., Djeu, J., Fortenbery, N., Epling-Burnette, P., Van Bijnen, S., Dolstra, H., Cannon, J., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci67580 · Cited by 316
“MDSC in humans characteristically express the surface transmembrane glycoprotein CD33, a Siglec 3 receptor that along with other members of this family, has prominent roles in inflammation (23, 26–35).”
Cytokine Storm—Definition, Causes, and Implications
Jarczak, D., & Nierhaus, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231911740 · Cited by 304
Rps14 haploinsufficiency causes a block in erythroid differentiation mediated by S100A8 and S100A9
Schneider, R. K., Schenone, M., Ferreira, M. V., Kramann, R., Joyce, C. E., Hartigan, C., Beier, F., Brümmendorf, T. H., Germing, U., Platzbecker, U., et al. (2016) · Nature Medicine · doi:10.1038/nm.4047 · Cited by 240
Salminen, A. (2022) · Ageing Research Reviews · doi:10.1016/j.arr.2022.101573 · Cited by 188
“There is convincing evidence that aging is associated with an increased immunosuppressive activity, e.g., involving expanded numbers of MDSCs and Tregs (Lages et al., 2008; Verschoor et al., 2013; Ruhland et al., 2016; Flores et al., 2017; Salminen, 2020).”
BackgroundInfluentialImmune checkpoint inhibitors and elderly people: A review
Daste, A., Domblides, C., Gross-goupil, M., Chakiba, C., Quivy, A., Cochin, V., de Mones, E., Larmonier, N., Soubeyran, P., & Ravaud, A. (2017) · European Journal of Cancer · doi:10.1016/j.ejca.2017.05.044 · Cited by 188
Idorn, M., Køllgaard, T., Kongsted, P., Sengeløv, L., & thor Straten, P. (2014) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-014-1591-2 · Cited by 184
Clements, V. K., Long, T., Long, R., Figley, C., Smith, D. M. C., & Ostrand-Rosenberg, S. (2018) · Journal of Leukocyte Biology · doi:10.1002/jlb.4hi0517-210r · Cited by 171
Immunosenescence, Inflammaging, and Frailty: Role of Myeloid Cells in Age-Related Diseases
Bleve, A., Motta, F., Durante, B., Pandolfo, C., Selmi, C., & Sica, A. (2022) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-021-08909-7 · Cited by 153
“Indeed, PMN-MDSCs were increased in the circulation of very old people (> 80 years), especially with a frailty profile, in comparison with younger subjects; conversely, the monocytic subset was found unchanged [82, 83].”
ResultFrom inflamm-aging to immune-paralysis: a slippery slope during aging for immune-adaptation
Fulop, T., Dupuis, G., Baehl, S., Le Page, A., Bourgade, K., Frost, E., Witkowski, J. M., Pawelec, G., Larbi, A., & Cunnane, S. (2016) · Biogerontology · doi:10.1007/s10522-015-9615-7 · Cited by 163
“Increased IL-4 production and increased numbers of suppressor cells such as Tregs or MDSCs also exemplify this anti-inflammatory reactive phenomenon which is most probably not efficient enough in the face of the sustained inflammatory processes with aging (Verschoor et al. 2013).”
BackgroundKnaul, J. K., Jörg, S., Oberbeck‐Müller, D., Heinemann, E., Scheuermann, L., Brinkmann, V., Mollenkopf, H., Yeremeev, V., Kaufmann, S. H. E., & Dorhoi, A. (2014) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201405-0828oc · Cited by 174
Salminen, A., Kaarniranta, K., & Kauppinen, A. (2019) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03048-x · Cited by 154
“[108] revealed that the levels of the CD11b+ CD15+-positive, granulocytic MDSCs were increased in the blood of community-dwelling seniors (61–76 years) and especially in frail elderly people (67–99 years).”
BackgroundActivation of immunosuppressive network in the aging process
Salminen, A. (2020) · Ageing Research Reviews · doi:10.1016/j.arr.2019.100998 · Cited by 151
Immunosenescence: signaling pathways, diseases and therapeutic targets
Fu, Y., Wang, B., Alu, A., Hong, W., Hong, L., He, X., Shi, H., Cheng, P., & Yang, X. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02371-z · Cited by 187
Pawelec, G. (2017) · Biogerontology · doi:10.1007/s10522-017-9682-z · Cited by 140
“…marker phenotyping of peripheral cells, we identified ''immune signatures'' informative for survival, in which the proportion of myeloid-derived suppressor cells (which have been reported to increase with age (Verschoor et al. 2013)) and responses to tumor antigens were crucial (Weide et al. 2014).”
BackgroundImmunotherapy comes of age: Immune aging & checkpoint inhibitors
Elias, R., Karantanos, T., Sira, E., & Hartshorn, K. L. (2017) · Journal of Geriatric Oncology · doi:10.1016/j.jgo.2017.02.001 · Cited by 133
Myeloid-Derived Suppressor Cells: Not Only in Tumor Immunity
Pawelec, G., Verschoor, C. P., & Ostrand‐Rosenberg, S. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01099 · Cited by 140
Self-citationTumor-induced myeloid dysfunction and its implications for cancer immunotherapy
Messmer, M. N., Netherby, C. S., Banik, D., & Abrams, S. I. (2015) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-014-1639-3 · Cited by 120
“increase with age [51, 67], which we posit contributes to”
BackgroundSalminen, A., Kauppinen, A., & Kaarniranta, K. (2019) · Journal of Molecular Medicine · doi:10.1007/s00109-019-01795-9 · Cited by 120
“The age-related expansion of MDSCs has been observed in humans [59, 60] and mice [61–63].”
BackgroundSalminen, A. (2021) · Journal of Molecular Medicine · doi:10.1007/s00109-021-02123-w · Cited by 117
“Accordingly, the number of MDSCs increased with aging in the blood of humans [112] and mice [113].”
BackgroundChesney, J. A., Mitchell, R. A., & Yaddanapudi, K. (2017) · Journal of Leukocyte Biology · doi:10.1189/jlb.5vmr1116-458rrr · Cited by 124
“These cells are also known to expand with aging [16].”
BackgroundAn Introduction to Automated Flow Cytometry Gating Tools and Their Implementation
Verschoor, C. P., Lelic, A., Bramson, J. L., & Bowdish, D. M. E. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00380 · Cited by 117
Self-citationFavaloro, J., Liyadipitiya, T., Brown, R., Yang, S., Suen, H., Woodland, N., Nassif, N., Hart, D., Fromm, P., Weatherburn, C., et al. (2014) · Leukemia & Lymphoma · doi:10.3109/10428194.2014.904511 · Cited by 113
Unraveling the Pathogenesis of MDS: The NLRP3 Inflammasome and Pyroptosis Drive the MDS Phenotype
Sallman, D. A., Cluzeau, T., Basiorka, A. A., & List, A. (2016) · Frontiers in Oncology · doi:10.3389/fonc.2016.00151 · Cited by 112
“Although MDSC expansion has been found to occur in relation to senescence-dependent changes in the BM (27), this expansion alone is inadequate to induce an MDS phenotype and suggests that the upregulation of pro-inflammatory molecules, such as S100A9, could be the initiating event in the development of MDS.”
BackgroundImmunosenescence is both functional/adaptive and dysfunctional/maladaptive
Fulop, T., Larbi, A., Hirokawa, K., Cohen, A. A., & Witkowski, J. M. (2020) · Seminars in Immunopathology · doi:10.1007/s00281-020-00818-9 · Cited by 108
Increased immunosuppression impairs tissue homeostasis with aging and age-related diseases
Salminen, A. (2020) · Journal of Molecular Medicine · doi:10.1007/s00109-020-01988-7 · Cited by 124
Flores, R. R., Clauson, C. L., Cho, J., Lee, B.-C., McGowan, S. J., Baker, D. J., Niedernhofer, L. J., & Robbins, P. D. (2017) · Aging Cell · doi:10.1111/acel.12571 · Cited by 107
“In one particular study, elderly patients were shown to have elevated levels of CD33HLA-DR CD11bCD15 MDSCs circulating in their blood compared with healthy adults (Verschoor et al., 2013).”
BackgroundSalminen, A., Kaarniranta, K., & Kauppinen, A. (2021) · Inflammation Research · doi:10.1007/s00011-021-01498-3 · Cited by 120
Immunosenescence and Novel Vaccination Strategies for the Elderly
Dorrington, M. G., & Bowdish, D. M. E. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00171 · Cited by 115
“Vaccination represents a cost-effective and efficient way to protect people from morbidity and mortality due to infections and, in addition, reduces hospitalizations, and the economic cost of lost productivity (Whitney et al., 2003; Jefferson et al., 2005).”
BackgroundSelf-citationThe role of myeloid-derived suppressor cells (MDSC) in the inflammaging process
Salminen, A., Kaarniranta, K., & Kauppinen, A. (2018) · Ageing Research Reviews · doi:10.1016/j.arr.2018.09.001 · Cited by 107
MDSCs in cancer: Conceiving new prognostic and therapeutic targets
Sanctis, F. D., Solito, S., Ugel, S., Molon, B., Bronte, V., & Marigo, I. (2015) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2015.08.001 · Cited by 111
“derived suppressor cells (MDSCs), represents a common trait of cancer and other noncancerous diseases, such as sepsis [4], bacterial [5], viral [6] and parasitical infections [7], autoimmune diseases [8] and aging [9].”
BackgroundLi, Z.-L., Ye, S., OuYang, L.-Y., Zhang, H., Chen, Y.-S., He, J., Chen, Q.-Y., Qian, C.-N., Zhang, X.-S., Cui, J., et al. (2015) · OncoImmunology · doi:10.1080/2162402x.2015.1044712 · Cited by 102
“Recently, several researchers proposed that PGE2 is indispensable for the induction and maintenance of MDSCs in cancer patients.(21,34,48) In the current study, we first revealed that the induction of T-MDSCs is hampered when COX-2 is suppressed in NPC cells in vitro.”
BackgroundBueno, V., Sant’Anna, O. A., & Lord, J. M. (2014) · AGE · doi:10.1007/s11357-014-9729-x · Cited by 98
Does patient age influence anti-cancer immunity?
Pawelec, G. (2018) · Seminars in Immunopathology · doi:10.1007/s00281-018-0697-6 · Cited by 99
ER stress activates immunosuppressive network: implications for aging and Alzheimer’s disease
Salminen, A., Kaarniranta, K., & Kauppinen, A. (2020) · Journal of Molecular Medicine · doi:10.1007/s00109-020-01904-z · Cited by 96
“Currently, there is convincing evidence that the numbers of immunosuppressiveMDSCs increases with aging in the blood of both humans [158, 159] and mice [160].”
BackgroundAging, immune senescence, and immunotherapy: a comprehensive review
Elias, R., Hartshorn, K., Rahma, O., Lin, N., & Snyder-Cappione, J. E. (2018) · Seminars in Oncology · doi:10.1053/j.seminoncol.2018.08.006 · Cited by 96
Macrophage function in the elderly and impact on injury repair and cancer
Duong, L., Radley‐Crabb, H. G., Lee, B. R., Dye, D. E., Pixley, F. J., Grounds, M. D., Nelson, D. J., & Jackaman, C. (2021) · Immunity & Ageing · doi:10.1186/s12979-021-00215-2 · Cited by 106
“We and others have shown that MDSCs increase in spleen, bone marrow and lymph nodes of healthy aged C57BL/6J female mice [32], albeit based on expression of CD11bGR-1 cells) and in peripheral blood in humans [89].”
Immunosenescence and vaccine failure in the elderly: strategies for improving response
Boraschi, D., & Italiani, P. (2014) · Immunology Letters · doi:10.1016/j.imlet.2014.06.006 · Cited by 86
Myeloid-derived suppressor cells (MDSC): an important partner in cellular/tissue senescence
Salminen, A., Kauppinen, A., & Kaarniranta, K. (2018) · Biogerontology · doi:10.1007/s10522-018-9762-8 · Cited by 84
“However, the senescence of immune cells with aging can decrease the efficiency of senescence surveillance (Vicente et al. 2016).”
BackgroundThe Role of Myeloid-Derived Suppressor Cells in Immune Ontogeny
Gantt, S., Gervassi, A., Jaspan, H., & Horton, H. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00387 · Cited by 76
“In addition, MDSC may also be increased in elderly mice (53) and humans (54), which might be involved with the phenomena of immunosenescence and “inflammaging.”
BackgroundChen, S., Liu, Y., Niu, Y., Xu, Y., Zhou, Q., Xu, X., Wang, J., & Yu, M. (2017) · Neuroscience Letters · doi:10.1016/j.neulet.2017.03.045 · Cited by 83
Fernandez, I. E., Greiffo, F. R., Frankenberger, M., Bandres, J., Heinzelmann, K., Neurohr, C., Hatz, R., Hartl, D., Behr, J., & Eickelberg, O. (2016) · European Respiratory Journal · doi:10.1183/13993003.01826-2015 · Cited by 75
Salminen, A. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101280 · Cited by 73
Clinical evaluation of systemic and local immune responses in cancer: time for integration
Gutkin, D. W., & Shurin, M. R. (2013) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-013-1480-0 · Cited by 82
“significantly higher in cancer patients compared with ageand sex-matched controls [116–120].”
BackgroundWitkowski, J. M., Fülöp, T., & Bryl, E. (2022) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2022.111672 · Cited by 98
Verschoor, C. P., Johnstone, J., Millar, J., Parsons, R., Lelic, A., Loeb, M., Bramson, J. L., & Bowdish, D. M. E. (2014) · PLoS ONE · doi:10.1371/journal.pone.0104522 · Cited by 71
“As an example, the recent finding in mice that a reduction of circulating pDCs stimulates myelopoiesis and increases circulating myeloid-derived suppressor cells (MDSCs) [17], whose numbers increase in the advanced-age, frail elderly [14], implies that there T a b le 2 .”
BackgroundMethodSelf-citationCharacterization of a whole blood assay for quantifying myeloid-derived suppressor cells
Apodaca, M. C., Wright, A. E., Riggins, A. M., Harris, W. P., Yeung, R. S. W., Yu, L., & Morishima, C. (2019) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-019-0674-1 · Cited by 66
Zhao, B., Wu, B. C., Feng, N., Zhang, X., Zhang, X., Wei, Y., & Zhang, W. (2023) · Journal of Hematology & Oncology · doi:10.1186/s13045-023-01426-4 · Cited by 80
Le Page, A., Garneau, H., Dupuis, G., Frost, E. H., Larbi, A., Witkowski, J. M., Pawelec, G., & Fülöp, T. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00783 · Cited by 65
“Myeloid-derived suppressor cells are the most important immune modulatory cells of the innate immune system (28).”
BackgroundInfluentialConsiderations for successful cancer immunotherapy in aged hosts
Hurez, V, Padrón, Á. S., Svatek, R. S., & Curiel, T. J. (2016) · Clinical and Experimental Immunology · doi:10.1111/cei.12875 · Cited by 65
Myeloid-derived suppressor cells in patients with myeloproliferative neoplasm
Wang, J. C. C., Kundra, A., Andrei, M., Baptiste, S., Chen, C., Wong, C., & Sindhu, H. (2016) · Leukemia Research · doi:10.1016/j.leukres.2016.02.004 · Cited by 61
Verschoor, C. P., Loukov, D., Naidoo, A., Puchta, A., Johnstone, J., Millar, J., Lelic, A., Novakowski, K. E., Dorrington, M. G., Loeb, M. B., et al. (2015) · Molecular Immunology · doi:10.1016/j.molimm.2015.01.015 · Cited by 67
Self-citationSenescence and cancer: An evolving inflammatory paradox
Ruhland, M. K., Coussens, L. M., & Stewart, S. A. (2016) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2015.10.001 · Cited by 60
“In addition to serum level cytokine increases, elevated numbers of circulating myeloid cells with T cell suppressive features have also been detected (77).”
Cancer Evo–Dev: A Theory of Inflammation-Induced Oncogenesis
Liu, W., Deng, Y., Li, Z., Chen, Y., Zhu, X., Tan, X., & Cao, G. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.768098 · Cited by 66
“Meanwhile, the levels of immunosuppressive myeloid-derived suppressor cells (MDSCs) and regulatory T (Treg) cells are upregulated by aging (50, 51).”
BackgroundReshef, R., Huffman, A. P., Gao, A., Luskin, M. R., Frey, N. V., Gill, S. I., Hexner, E. O., Kambayashi, T., Loren, A. W., Luger, S. M., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.60.1203 · Cited by 60
Here, There, and Everywhere: Myeloid-Derived Suppressor Cells in Immunology
Ostrand‐Rosenberg, S., Lamb, T. J., & Pawelec, G. (2023) · The Journal of Immunology · doi:10.4049/jimmunol.2200914 · Cited by 63
Optimization of Immunotherapy in Elderly Cancer Patients
Tomihara, K., Curiel, T. J., & Zhang, B. (2013) · Critical Reviews in Oncogenesis · doi:10.1615/critrevoncog.2013010591 · Cited by 58
Clinical perspectives on the age-related increase of immunosuppressive activity
Salminen, A. (2022) · Journal of Molecular Medicine · doi:10.1007/s00109-022-02193-4 · Cited by 57
Lepone, L. M., Donahue, R. N., Grenga, I., Metenou, S., Richards, J., Heery, C. R., Madan, R. A., Gulley, J. L., & Schlom, J. (2016) · Journal of Circulating Biomarkers · doi:10.5772/62322 · Cited by 58
“an older group, above the age of 65 [33, 34]; other studies have also used an older cut-off ranging between 60-65 years of age in order to separate older from younger individuals [35-37].”
Immune Biomarkers Predictive of Respiratory Viral Infection in Elderly Nursing Home Residents
Johnstone, J., Parsons, R., Botelho, F., Millar, J., McNeil, S., Fulop, T., McElhaney, J., Andrew, M. K., Walter, S. D., Devereaux, P. J., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0108481 · Cited by 55
“Antibody staining was performed using a Beckman Coulter Biomek NX p Laboratory Automation Workstation (Beckman Coulter, Ontario) as previously described [29] , followed by analysis using an LSR II flow cytometer with a high-throughput sampler (BD Biosciences, NJ, USA).”
MethodSelf-citationT‐Cell Phenotypes Predictive of Frailty and Mortality in Elderly Nursing Home Residents
Johnstone, J., Parsons, R., Botelho, F. M., Millar, J., McNeil, S., Fülöp, T., McElhaney, J. E., Andrew, M. K., Walter, S. D., Devereaux, P. J., et al. (2016) · Journal of the American Geriatrics Society · doi:10.1111/jgs.14507 · Cited by 57
Self-citationImmunotherapy in older patients with cancer
Granier, C., Gey, A., Roncelin, S., Weiss, L., Paillaud, É., & Tartour, É. (2020) · Biomedical Journal · doi:10.1016/j.bj.2020.07.009 · Cited by 63
“[8] Verschoor CP, Johnstone J, Millar J, Dorrington MG, Habibagahi M, Lelic A, et al.”
BackgroundImmunesenescence: A Predisposing Risk Factor for the Development of COVID-19?
Hazeldine, J., & Lord, J. M. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.573662 · Cited by 67
Ageing and respiratory infections: The airway of ageing
Haq, K., & McElhaney, J. E. (2014) · Immunology Letters · doi:10.1016/j.imlet.2014.06.009 · Cited by 63
As we age: Does slippage of quality control in the immune system lead to collateral damage?
Müller, L., & Pawelec, G. (2015) · Ageing Research Reviews · doi:10.1016/j.arr.2015.01.005 · Cited by 55
A comprehensive assessment of immunophenotyping performed in cryopreserved peripheral whole blood
Verschoor, C. P., Kohli, V., & Balion, C. M. (2017) · Cytometry Part B Clinical Cytometry · doi:10.1002/cyto.b.21526 · Cited by 52
“staining followed by fixation and storage (9), storage for extended periods at 48C, followed by staining and immediate analysis (10), immediate lysis and fixation, followed by storage and subsequent staining and analysis (11), and lastly, the isolation and cryopreservation of peripheral blood mononuclear cells (PBMCs)…”
MethodSelf-citationSun, S., Ni, S.-H., Li, Y., Liu, X., Deng, J., Chen, Z., Li, H., Feng, W., Huang, Y., Li, D.-N., et al. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-03874-7 · Cited by 54
Tolerance and immune suppression in the tumor microenvironment
Ostrand‐Rosenberg, S. (2015) · Cellular Immunology · doi:10.1016/j.cellimm.2015.09.011 · Cited by 56
“Elevated levels of MDSC are also associated with normal aging [34, 35].”
BackgroundMyeloid derived suppressor cells in inflammatory conditions of the central nervous system
Melero‐Jerez, C., Ortega, M. C., Moliné-Velázquez, V., & Clemente, D. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2015.10.015 · Cited by 51
“5) Eniuontina et al., 2011; Hertzenberg et al., 2013; Verschoor et al., 2013.”
BackgroundParameters of the Immune System and Vitamin D Levels in Old Individuals
Alves, A. S., Ishimura, M. E., Duarte, Y. A. D. O., & Bueno, V. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01122 · Cited by 53
“observed a significant increase in the frequency of MDSC compared to young adults in addition to the higher number of MDSC in older individuals with frailty and previous history of cancer (11).”
BackgroundResultMDSCs, ageing and inflammageing
Pawelec, G., Picard, E., Bueno, V., Verschoor, C. P., & Ostrand‐Rosenberg, S. (2021) · Cellular Immunology · doi:10.1016/j.cellimm.2021.104297 · Cited by 54
Self-citationZhao, A., Xu, H., Kang, X., Zhao, A., & Lu, L. (2015) · Journal of Reproductive Immunology · doi:10.1016/j.jri.2015.11.001 · Cited by 53
Innate Immune Cells and Their Contribution to T-Cell-Based Immunotherapy
Ginefra, P., Lorusso, G., & Vannini, N. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21124441 · Cited by 49
“One important example is the expansion in aged individuals of the heterogeneous population of immature MDSCs [175].”
BackgroundInfluentialSalminen, A., Kaarniranta, K., & Kauppinen, A. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102296 · Cited by 53
Considerations for successful cancer immunotherapy in aged hosts
Hurez, V., Padrón, Á., Svatek, R. S., & Curiel, T. J. (2018) · Experimental Gerontology · doi:10.1016/j.exger.2017.10.002 · Cited by 46
“MDSCs increase in blood during human aging (Verschoor et al., 2013) and increase in lymphoid organs in mice (Hurez et al., 2012; Jackaman et al., 2013).”
BackgroundAlves, A. S., & Bueno, V. (2019) · Einstein (São Paulo) · doi:10.31744/einstein_journal/2019rb4733 · Cited by 60
Sharma, R. (2021) · Biogerontology · doi:10.1007/s10522-021-09936-9 · Cited by 55
Age effects of distinct immune checkpoint blockade treatments in a mouse melanoma model
Padrón, Á., Hurez, V., Gupta, H. B., Clark, C. A., Pandeswara, S. L., Yuan, B., Svatek, R. S., Turk, M. J., Drerup, J. M., Li, R., et al. (2018) · Experimental Gerontology · doi:10.1016/j.exger.2017.12.025 · Cited by 44
Immune Checkpoint Blockade for Advanced NSCLC: A New Landscape for Elderly Patients
Perrotta, F., Rocco, D., Vitiello, F., Palma, R. D., Guerra, G., Luca, A. D., Navani, N., & Bianco, A. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20092258 · Cited by 45
“In elderly patients, the number of MDSCs increases both in tumor stroma and in the circulation [36,53] and in older mice this increase corresponds to a greater susceptibility to lung cancer [54].”
BackgroundZhong, L., Liu, Z., Zhou, X., Song, S., Weng, G.-Y., Wen, Y., Liu, F., Cao, D., & Liu, Y. (2019) · Oral Oncology · doi:10.1016/j.oraloncology.2019.06.004 · Cited by 47
Cancer Immunotherapies: Are They as Effective in the Elderly?
Poropatich, K., Fontanarosa, J., Samant, S., Sosman, J. A., & Zhang, B. (2017) · Drugs & Aging · doi:10.1007/s40266-017-0479-1 · Cited by 42
“When stratified by age, human subjects[67 years of age (n = 131) have been shown to have significantly higher levels of circulating HLA-DRCD33 MDSC, particularly the myeloid subset (CD11bCD15), compared with subjects\60 years of age (n = 41) [37].”
BackgroundNormal Aging and Its Role in Cancer Metastasis
Fane, M. E., & Weeraratna, A. T. (2019) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a037341 · Cited by 45
“MDSCs show a consistent increase during aging in human blood (Verschoor et al. 2013), bone marrow and lymphoid organs (Hurez et al.”
BackgroundHazeldine, J., Lord, J. M., & Hampson, P. (2015) · Ageing Research Reviews · doi:10.1016/j.arr.2015.10.003 · Cited by 45
Gomes, F., Wong, M. L., Battisti, N. M. L., Kordbacheh, T., Kiderlen, M., Greystoke, A., & Luciani, A. (2020) · British Journal of Cancer · doi:10.1038/s41416-020-0986-4 · Cited by 45
Tumor-Induced Myeloid-Derived Suppressor Cells
Sanctis, F. D., Bronte, V., & Ugel, S. (2016) · Microbiology Spectrum · doi:10.1128/microbiolspec.mchd-0016-2015 · Cited by 39
Ren, W., Zhang, X., Li, W., Feng, Q., Feng, H., Tong, Y., Rong, H., Wang, W., Zhang, D., Zhang, Z., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-64841-4 · Cited by 41
Salminen, A., Kaarniranta, K., & Kauppinen, A. (2020) · Cellular Signalling · doi:10.1016/j.cellsig.2020.109771 · Cited by 38
Impact of immunosenescence and inflammaging on the effects of immune checkpoint inhibitors
Hou, C., Wang, Z., & Lu, X. (2023) · Cancer Pathogenesis and Therapy · doi:10.1016/j.cpt.2023.08.001 · Cited by 44
“19 These cells secrete cytokines, such as interleukin-10 (IL-10) and transforming growth factor-beta (TGF-β ), which can suppress antitumor responses.”
BackgroundEnhancing immunity during ageing by targeting interactions within the tissue environment
Bracken, O. V., Maeyer, R. P. H. D., & Akbar, A. N. (2025) · Nature Reviews Drug Discovery · doi:10.1038/s41573-024-01126-9 · Cited by 45
Myeloid-Derived Suppressor Cells at the Intersection of Inflammaging and Bone Fragility
Kirkwood, K. L., Zhang, L., Thiyagarajan, R., Seldeen, K. L., & Troen, B. R. (2018) · Immunological Investigations · doi:10.1080/08820139.2018.1552360 · Cited by 39
“Aging and metabolic disease have clearly been shown to enhance MDSC expansion (Bao et al., 2015; Jackaman and Nelson, 2014; Verschoor et al., 2013).”
BackgroundAndersson, S. E. M., Lange, E., Kucharski, D., Svedlund, S., Önnheim, K., Bergquist, M., Josefsson, E., Lord, J. M., Mårtensson, I., Mannerkorpi, K., et al. (2020) · Immunity & Ageing · doi:10.1186/s12979-020-00184-y · Cited by 38
Immunosenescence: A Critical Factor Associated With Organ Injury After Sepsis
Lü, X., Yang, Y.-M., & Lu, Y. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.917293 · Cited by 37
Xie, G., Luo, H., Pang, L., Peng, B., Winkelmann, E., McGruder, B., Hesse, J., Whiteman, M. C., Campbell, G. A., Milligan, G. N., et al. (2015) · Journal of Virology · doi:10.1128/jvi.02488-15 · Cited by 35
“335 Accumulating evidence shows immune suppression increases with age (40, 41).”
Background
Metadata
- Authors
- Verschoor, C. P., Johnstone, J., Millar, J., Dorrington, M. G., Habibagahi, M., Lelic, A., Loeb, M., Bramson, J. L., & Bowdish, D. M. E.
- Affiliations
- Michael G. DeGroote Institute for Infectious Disease Research (CA)
- Shiraz University of Medical Sciences (IR)
- Corresponding author
- Bowdish, Dawn M E
- ORCID
- Venue
- Journal of Leukocyte Biology
- Publisher
- Oxford University Press (OUP)
- Published
- 2013-04-01
- Volume
- 93
- Issue
- 4
- Pages
- 633-637
- ISSN
- 0741-5400 (ISSN-L)
- 1938-3673
- PMC
- PMC3701116
- OpenAlex
- W2095746947
- Cited by
- 235
- References
- 39
- Citations by year
- 2026: 10 · 2025: 15 · 2024: 18 · 2023: 12 · 2022: 16 · 2021: 27 · 2020: 21 · 2019: 19 · 2018: 19 · 2017: 19 · 2016: 16 · 2015: 18 · 2014: 16 · 2013: 8
- FWCI
- 10.68
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Locations
- Journal of Leukocyte Biology (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Funders
- Canadian Institutes of Health Research
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Life Sciences › Immunology and Microbiology › Immunology › Phagocytosis and Immune Regulation
- Keywords
- myeloid-derived suppressor cells, aging, frail elderly, cancer history, immunosenescence, immunosuppression, inflammatory cytokines, TNF-α, interleukin-6, IL-1β
- MeSH terms
- Adult, Aged, Aged, 80 and over, Aging, Cell Differentiation, Female, Fucosyltransferases, HLA-DR Antigens, Humans, Male, Middle Aged, Neoplasms, Tumor Necrosis Factor-alpha, Interleukin-6, Gene Expression, Immunophenotyping, Lewis X Antigen, Myeloid Cells, CD11b Antigen, Interleukin-1beta, Sialic Acid Binding Ig-like Lectin 3
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.